Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Steve Landrum who wrote (28625)	3/31/1999 3:12:00 AM
From: Cheryl Galt	Read Replies (2) \| Respond to of 32384

Tomorrow should be interesting. I wonder if anyone getting his information from Dow Jones, instead of from the original Ligand press release, will be willing to pay extra for his shares tomorrow -- based on that nice frosting DJ tacked onto their version of the release. Talk about misinformation! When DJ does it, they don't mess around ... -------------------------------------------------------- Dow Jones Newswires -- March 30, 1999 Ligand, Spanish Firm In 10-Yr Oncology Pdts Supply Pact>LGND (Corrected 6:35 PM) ... Ligand, which had 1998 sales of $1.26 billion ... -------------------------------------------------------- I wonder if DJ will issue a re-corrected press release tomorrow. (I wonder where DJ came up with that particular $1.26B figure. Rezulin's been in the news a lot lately, and has sold more than $1B so far. I'll bet that's the amount of sales revenue that's come in from Rezulin.)